Cargando…
Vaccination with (1–11)E2 in alum efficiently induces an antibody response to β-amyloid without affecting brain β-amyloid load and microglia activation in 3xTg mice
Immunization against β-amyloid (Aβ) is pursued as a possible strategy for the prevention of Alzheimer’s disease (AD). In clinical trials, Aβ 1–42 proved poorly immunogenic and caused severe adverse effects; therefore, safer and more immunogenic candidate vaccines are needed. Multimeric protein (1–11...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081683/ https://www.ncbi.nlm.nih.gov/pubmed/31758499 http://dx.doi.org/10.1007/s40520-019-01414-0 |
_version_ | 1783685694369038336 |
---|---|
author | Mantile, Francesca Capasso, Angelo Villacampa, Nadia Donnini, Maria Liguori, Giovanna L. Constantin, Gabriela De Berardinis, Piergiuseppe Heneka, Michael T. Prisco, Antonella |
author_facet | Mantile, Francesca Capasso, Angelo Villacampa, Nadia Donnini, Maria Liguori, Giovanna L. Constantin, Gabriela De Berardinis, Piergiuseppe Heneka, Michael T. Prisco, Antonella |
author_sort | Mantile, Francesca |
collection | PubMed |
description | Immunization against β-amyloid (Aβ) is pursued as a possible strategy for the prevention of Alzheimer’s disease (AD). In clinical trials, Aβ 1–42 proved poorly immunogenic and caused severe adverse effects; therefore, safer and more immunogenic candidate vaccines are needed. Multimeric protein (1–11)E2 is able to induce an antibody response to Aβ, immunological memory, and IL-4 production, with no concomitant anti-Aβ T cell response. Antisera recognize Aβ oligomers, protofibrils, and fibrils. In this study, we evaluated the effect of prophylactic immunization with three doses of (1–11)E2 in alum in the 3xTg mouse model of AD. Immunization with (1–11)E2 efficiently induced anti-Aβ antibodies, but afforded no protection against Aβ accumulation and neuroinflammation. The identification of the features of the anti-Aβ immune response that correlate with the ability to prevent Aβ accumulation remains an open problem that deserves further investigation. |
format | Online Article Text |
id | pubmed-8081683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-80816832021-05-05 Vaccination with (1–11)E2 in alum efficiently induces an antibody response to β-amyloid without affecting brain β-amyloid load and microglia activation in 3xTg mice Mantile, Francesca Capasso, Angelo Villacampa, Nadia Donnini, Maria Liguori, Giovanna L. Constantin, Gabriela De Berardinis, Piergiuseppe Heneka, Michael T. Prisco, Antonella Aging Clin Exp Res Short Communication Immunization against β-amyloid (Aβ) is pursued as a possible strategy for the prevention of Alzheimer’s disease (AD). In clinical trials, Aβ 1–42 proved poorly immunogenic and caused severe adverse effects; therefore, safer and more immunogenic candidate vaccines are needed. Multimeric protein (1–11)E2 is able to induce an antibody response to Aβ, immunological memory, and IL-4 production, with no concomitant anti-Aβ T cell response. Antisera recognize Aβ oligomers, protofibrils, and fibrils. In this study, we evaluated the effect of prophylactic immunization with three doses of (1–11)E2 in alum in the 3xTg mouse model of AD. Immunization with (1–11)E2 efficiently induced anti-Aβ antibodies, but afforded no protection against Aβ accumulation and neuroinflammation. The identification of the features of the anti-Aβ immune response that correlate with the ability to prevent Aβ accumulation remains an open problem that deserves further investigation. Springer International Publishing 2019-11-22 2021 /pmc/articles/PMC8081683/ /pubmed/31758499 http://dx.doi.org/10.1007/s40520-019-01414-0 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Short Communication Mantile, Francesca Capasso, Angelo Villacampa, Nadia Donnini, Maria Liguori, Giovanna L. Constantin, Gabriela De Berardinis, Piergiuseppe Heneka, Michael T. Prisco, Antonella Vaccination with (1–11)E2 in alum efficiently induces an antibody response to β-amyloid without affecting brain β-amyloid load and microglia activation in 3xTg mice |
title | Vaccination with (1–11)E2 in alum efficiently induces an antibody response to β-amyloid without affecting brain β-amyloid load and microglia activation in 3xTg mice |
title_full | Vaccination with (1–11)E2 in alum efficiently induces an antibody response to β-amyloid without affecting brain β-amyloid load and microglia activation in 3xTg mice |
title_fullStr | Vaccination with (1–11)E2 in alum efficiently induces an antibody response to β-amyloid without affecting brain β-amyloid load and microglia activation in 3xTg mice |
title_full_unstemmed | Vaccination with (1–11)E2 in alum efficiently induces an antibody response to β-amyloid without affecting brain β-amyloid load and microglia activation in 3xTg mice |
title_short | Vaccination with (1–11)E2 in alum efficiently induces an antibody response to β-amyloid without affecting brain β-amyloid load and microglia activation in 3xTg mice |
title_sort | vaccination with (1–11)e2 in alum efficiently induces an antibody response to β-amyloid without affecting brain β-amyloid load and microglia activation in 3xtg mice |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081683/ https://www.ncbi.nlm.nih.gov/pubmed/31758499 http://dx.doi.org/10.1007/s40520-019-01414-0 |
work_keys_str_mv | AT mantilefrancesca vaccinationwith111e2inalumefficientlyinducesanantibodyresponsetobamyloidwithoutaffectingbrainbamyloidloadandmicrogliaactivationin3xtgmice AT capassoangelo vaccinationwith111e2inalumefficientlyinducesanantibodyresponsetobamyloidwithoutaffectingbrainbamyloidloadandmicrogliaactivationin3xtgmice AT villacampanadia vaccinationwith111e2inalumefficientlyinducesanantibodyresponsetobamyloidwithoutaffectingbrainbamyloidloadandmicrogliaactivationin3xtgmice AT donninimaria vaccinationwith111e2inalumefficientlyinducesanantibodyresponsetobamyloidwithoutaffectingbrainbamyloidloadandmicrogliaactivationin3xtgmice AT liguorigiovannal vaccinationwith111e2inalumefficientlyinducesanantibodyresponsetobamyloidwithoutaffectingbrainbamyloidloadandmicrogliaactivationin3xtgmice AT constantingabriela vaccinationwith111e2inalumefficientlyinducesanantibodyresponsetobamyloidwithoutaffectingbrainbamyloidloadandmicrogliaactivationin3xtgmice AT deberardinispiergiuseppe vaccinationwith111e2inalumefficientlyinducesanantibodyresponsetobamyloidwithoutaffectingbrainbamyloidloadandmicrogliaactivationin3xtgmice AT henekamichaelt vaccinationwith111e2inalumefficientlyinducesanantibodyresponsetobamyloidwithoutaffectingbrainbamyloidloadandmicrogliaactivationin3xtgmice AT priscoantonella vaccinationwith111e2inalumefficientlyinducesanantibodyresponsetobamyloidwithoutaffectingbrainbamyloidloadandmicrogliaactivationin3xtgmice |